George Βertsias
About
George Βertsias is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, George Βertsias has authored 230 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Rheumatology, 94 papers in Immunology and 38 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in George Βertsias's work include Systemic Lupus Erythematosus Research (144 papers), Atherosclerosis and Cardiovascular Diseases (44 papers) and Monoclonal and Polyclonal Antibodies Research (34 papers). George Βertsias is often cited by papers focused on Systemic Lupus Erythematosus Research (144 papers), Atherosclerosis and Cardiovascular Diseases (44 papers) and Monoclonal and Polyclonal Antibodies Research (34 papers). George Βertsias collaborates with scholars based in Greece, United States and Germany. George Βertsias's co-authors include Dimitrios T. Boumpas, Antonis Fanouriakis, Prodromos Sidiropoulos, Nikolaos Tziolos, Irini Gergianaki, Eva D. Papadimitraki, Christina Adamichou, Manolis Linardakis, H Kritikos and Amalia Raptopoulou and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.
In The Last Decade
George Βertsias
214 papers receiving 6.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| George Βertsias Greece | 44 | 3.5k | 2.9k | 1.0k | 746 | 650 | 230 | 6.2k | ||
| Fabrizio Conti Italy | 47 | 3.6k 1.0× | 2.0k 0.7× | 1.2k 1.1× | 762 1.0× | 584 0.9× | 320 | 6.6k | ||
| W. Joseph McCune United States | 43 | 3.6k 1.0× | 3.1k 1.1× | 944 0.9× | 881 1.2× | 701 1.1× | 99 | 6.2k | ||
| Rieke Alten Germany | 45 | 6.5k 1.8× | 3.3k 1.1× | 800 0.8× | 842 1.1× | 881 1.4× | 221 | 9.6k | ||
| Christophe Richez France | 37 | 2.4k 0.7× | 2.2k 0.8× | 618 0.6× | 552 0.7× | 551 0.8× | 148 | 4.6k | ||
| Lai‐Shan Tam Hong Kong | 55 | 5.9k 1.7× | 4.6k 1.6× | 1.5k 1.4× | 641 0.9× | 761 1.2× | 290 | 10.2k | ||
| Gisele Zandman‐Goddard Israel | 48 | 2.8k 0.8× | 2.0k 0.7× | 753 0.7× | 767 1.0× | 1.0k 1.6× | 142 | 6.3k | ||
| Prodromos Sidiropoulos Greece | 41 | 2.9k 0.8× | 2.4k 0.8× | 1.1k 1.1× | 372 0.5× | 444 0.7× | 164 | 5.4k | ||
| Martin Aringer Germany | 51 | 4.1k 1.2× | 3.0k 1.0× | 1.2k 1.1× | 903 1.2× | 991 1.5× | 232 | 7.5k | ||
| Susan Manzi United States | 45 | 5.1k 1.4× | 3.9k 1.3× | 614 0.6× | 1.2k 1.6× | 667 1.0× | 118 | 6.8k | ||
| Mauro Galeazzi Italy | 49 | 3.8k 1.1× | 1.9k 0.6× | 2.0k 1.9× | 593 0.8× | 576 0.9× | 199 | 7.9k |
Countries citing papers authored by George Βertsias
Since
Specialization
Citations
This map shows the geographic impact of George Βertsias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Βertsias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Βertsias more than expected).
Fields of papers citing papers by George Βertsias
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by George Βertsias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Βertsias. The network helps show where George Βertsias may publish in the future.
Co-authorship network of co-authors of George Βertsias
This figure shows the co-authorship network connecting the top 25 collaborators of George Βertsias. A scholar is included among the top collaborators of George Βertsias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Βertsias. George Βertsias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Argyros, Orestis, Konstantinos C. Tsolis, George Βertsias, et al.. (2026). DNA damage in macrophages drives immune autoreactivity via nuclear antigen presentation. Nature Aging. 6(2). 393–413.
2.
Silvagni, Ettore, Argyro Repa, Konstantinos Parperis, et al.. (2025). Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study. RMD Open. 11(1). e005118–e005118.
3.
Garantziotis, Panagiotis, Dionysis Nikolopoulos, Anastasia Filia, et al.. (2025). Transcriptome analysis to decipher the molecular underpinnings of response to treatment in systemic lupus erythematosus. RMD Open. 11(1). e005050–e005050.
4.
Ruhanen, Hanna, Minna Holopainen, Reijo Käkelä, et al.. (2024). Improvement of high-density lipoprotein atheroprotective properties in patients with systemic lupus erythematosus after belimumab treatment. Lara D. Veeken. 64(2). 648–657.
5.
Bertsias, Antonios, et al.. (2024). Difficult-to-Manage Axial Spondyloarthritis. Mediterranean Journal of Rheumatology. 35(Suppl 3). 542–542.
6.
Garantziotis, Panagiotis, Ettore Silvagni, Argyro Repa, et al.. (2024). Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression. Annals of the Rheumatic Diseases. 83(4). 464–474.
7.
Papadaki, Efrosini, Vasileios Mastorodemos, Pantelis Constantoulakis, et al.. (2023). Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors?. Journal of Clinical Medicine. 12(21). 6945–6945.
8.
Banos, Aggelos & George Βertsias. (2023). Flares in Lupus Nephritis: Risk Factors and Strategies for Their Prevention. Current Rheumatology Reports. 25(10). 183–191.
9.
Boumpas, Dimitrios T., et al.. (2023). Management of systemic lupus erythematosus: A new scenario. Best Practice & Research Clinical Rheumatology. 37(4). 101895–101895.
10.
Burska, Agata, Javier Rodríguez‐Carrio, Robert Biesen, et al.. (2023). Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider. RMD Open. 9(1). e002876–e002876.
11.
Repa, Argyro, Antonios Bertsias, Jérôme Zoidakis, et al.. (2023). A Peripheral Blood Signature of Increased Th1 and Myeloid Cells Combined with Serum Inflammatory Mediators Is Associated with Response to Abatacept in Rheumatoid Arthritis Patients. Cells. 12(24). 2808–2808.
12.
Kostopoulou, Myrto, Antonis Fanouriakis, George Βertsias, & Dimitrios T. Boumpas. (2023). Annals of the Rheumatic Diseases collection on lupus nephritis (2019–2022): novel insights and advances in therapy. Annals of the Rheumatic Diseases. 82(6). 729–733.
13.
Nikolopoulos, Dionysis, et al.. (2021). First Diagnosis of Systemic Lupus Erythematosus in Hospitalized Patients: Clinical Phenotypes and Pitfalls for the Non-Specialist. The American Journal of Medicine. 135(2). 244–253.e3.
14.
Nikolopoulos, Dionysis, Antonis Fanouriakis, & George Βertsias. (2021). Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives. Expert Review of Clinical Immunology. 17(4). 317–329.
15.
Adamichou, Christina, Dionysis Nikolopoulos, Argyro Repa, et al.. (2021). Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus. Annals of the Rheumatic Diseases. 80(6). 758–766.
16.
Kostopoulou, Myrto, Christina Adamichou, & George Βertsias. (2020). An Update on the Diagnosis and Management of Lupus Nephritis. Current Rheumatology Reports. 22(7). 30–30.
17.
Panopoulos, Stylianos, Κonstantinos Thomas, Georgios Georgiopoulos, et al.. (2020). Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study. Lara D. Veeken. 60(1). 170–178.
18.
Nikolopoulos, Dionysis, Matilda Papathanasiou, Maria Chondrogianni, et al.. (2020). Demyelination with autoimmune features: a distinct clinical entity? Results from a longitudinal cohort. Lara D. Veeken. 60(9). 4166–4174.
19.
Adamichou, Christina, Dionysis Nikolopoulos, Alessandra Bortoluzzi, et al.. (2019). In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment. Annals of the Rheumatic Diseases. 79(2). 232–241.
20.
Mammas, Ioannis, George Βertsias, Manolis Linardakis, Joanna Moschandreas, & Anthony Kafatos. (2003). Nutrient intake and food consumption among medical students in Greece assessed during a Clinical Nutrition course. International Journal of Food Sciences and Nutrition. 55(1). 17–26.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Fabrizio Conti Breakdown of academic impact, for papers by W. Joseph McCune Breakdown of academic impact, for papers by Rieke Alten Breakdown of academic impact, for papers by Christophe Richez Breakdown of academic impact, for papers by Lai‐Shan Tam Breakdown of academic impact, for papers by Gisele Zandman‐Goddard Breakdown of academic impact, for papers by Prodromos Sidiropoulos Breakdown of academic impact, for papers by Martin Aringer Breakdown of academic impact, for papers by Susan Manzi Breakdown of academic impact, for papers by Mauro Galeazzi